Categories: Sports

Parimatch Launches Exclusive Markets Curated by Cricket Legend Sir Vivian Richards

As the Indian T20 League approaches its final stage, the excitement and tension are reaching a fever pitch. To keep the energy high, Parimatch has introduced a series of exclusive markets, curated by none other than cricketing legend and sharp-eyed sports analyst Sir Vivian Richards.

- Advertisement -

Renowned for his fearless playing style and unmatched cricketing IQ, Sir Vivian Richards has partnered with Parimatch to bring fans even closer to the game. As part of this collaboration, he has curated key markets where every fan can channel their passion and prediction skills. This is your chance to wrap up the Indian T20 League on a smart note-with expert-guided predictions and the opportunity to win big along the way.

- Advertisement -

Parimatch Launches Exclusive Markets Curated by Cricket Legend Sir Vivian Richards

- Advertisement -

Exclusive Markets Curated by Sir Vivian Richards:

- Advertisement -
  • IPL 2025: Playoff Top 4 – Which teams will seal their spot in the final four

  • IPL 2025: Cap Contenders – Who’s chasing the Orange and Purple Caps Make your call!

  • IPL 2025: Most Catches – Predict the safest hands in the outfield.

  • IPL 2025: Champion Prediction – It all comes down to this: who will lift the trophy

Sir Vivian Richards commented,“The Indian Cricket League is full of surprises, but there are always patterns if you know where to look. With Parimatch, we’ve created markets that highlight the most decisive moments of the tournament-the ones I’d be watching closely if I were in the fans’ shoes.”

- Advertisement -

Running until June 3, 2025, the Indian T20 League promises high-stakes action. Parimatch invites fans to explore exclusive markets and win big on their favourite players and teams-all the way to the final.

- Advertisement -

For the latest updates and to explore other exclusive markets, please visit Parimatch’s official website.

- Advertisement -
News Voir

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago